Science Group PLC
LSE:SAG
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/FCFE
Price to Free Cash Flow to Equity (P/FCFE) ratio compares a company`s market value to the free cash flow available to its shareholders. It`s similar to the P/OCF ratio but more precise, since it accounts for capital expenditures deducted from operating cash flow.
Price to Free Cash Flow to Equity (P/FCFE) ratio compares a company`s market value to the free cash flow available to its shareholders. It`s similar to the P/OCF ratio but more precise, since it accounts for capital expenditures deducted from operating cash flow.
Valuation Scenarios
If P/FCFE returns to its 3-Year Average (15.2), the stock would be worth GBX719.48 (26% upside from current price).
| Scenario | P/FCFE Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 12.1 | GBX572 |
0%
|
| 3-Year Average | 15.2 | GBX719.48 |
+26%
|
| 5-Year Average | 15.2 | GBX719.48 |
+26%
|
| Industry Average | 0.2 | GBX7.96 |
-99%
|
| Country Average | 0.2 | GBX9.67 |
-98%
|
Forward P/FCFE
Today’s price vs future free cash flow to equity
Peer Comparison
| Market Cap | P/FCFE | P/E | ||||
|---|---|---|---|---|---|---|
| UK |
|
Science Group PLC
LSE:SAG
|
246.8m GBP | 12.1 | 7.4 | |
| UK |
|
Relx PLC
LSE:REL
|
49.1B GBP | 17.5 | 23.8 | |
| UK |
I
|
IHS Markit Ltd
F:0M3
|
37.9B EUR | 60 | 36.5 | |
| CA |
|
Thomson Reuters Corp
TSX:TRI
|
57.8B CAD | 36.7 | 27.8 | |
| IE |
|
Experian PLC
LSE:EXPN
|
25B GBP | 23 | 24.8 | |
| US |
|
Verisk Analytics Inc
NASDAQ:VRSK
|
25.1B USD | 9.1 | 27.6 | |
| CH |
|
SGS SA
SIX:SGSN
|
16.3B CHF | 9.9 | 24.6 | |
| US |
|
Equifax Inc
NYSE:EFX
|
20.7B USD | 14 | 29.7 | |
| US |
|
Leidos Holdings Inc
NYSE:LDOS
|
18.9B USD | 13.1 | 13 | |
| US |
U
|
UL Solutions Inc
NYSE:ULS
|
18.4B USD | 0 | 0 | |
| NL |
|
Wolters Kluwer NV
AEX:WKL
|
15B EUR | 7.3 | 11.5 |
Market Distribution
| Min | 0 |
| 30th Percentile | 0.1 |
| Median | 0.2 |
| 70th Percentile | 0.4 |
| Max | 901.8 |
Other Multiples
Science Group PLC
Glance View
Science Group Plc engages in the provision of science and technology-based consultancy services. The company is headquartered in Cambridge, Cambridgeshire and currently employs 410 full-time employees. The company went IPO on 2008-07-08. The firm's segments include Services Operating Business, Product Operating Business and Freehold Properties. The Services Operating Business segment comprises two operating divisions: R&D Consultancy and Regulatory & Compliance. The Product Operating Business segment includes Frontier Smart Technologies, the third operating division. The company provides products and services to clients in the vertical markets of medical, food and beverage, industrial and consumer. The company owns two freehold properties, Harston Mill near Cambridge and Great Burgh in Epsom. Its subsidiaries include Sagentia Limited, Sagentia Technology Advisory Limited, OTM Consulting Ltd, Quadro Epsom Limited, Sagentia Inc., OTM Consulting Inc., Oakland Innovation Ltd, Leatherhead Research Limited, Technology Sciences Group Limited and SG Bidco Ltd, among others.
